Drug Delivery and Targeting
Since the publication of the Handbook of Experimental Pharmacology Vol. 197 in 2010 there have been important advances in drug development, drug delivery and – more recently – drug targeting. This is in particular relevant with the new generation of drugs acting on the immune system and tumors. Thes...
Сохранить в:
| Соавтор: | |
|---|---|
| Другие авторы: | , |
| Формат: | Электронный ресурс eКнига |
| Язык: | английский |
| Опубликовано: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| Редактирование: | 1st ed. 2024. |
| Серии: | Handbook of Experimental Pharmacology,
284 |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1007/978-3-031-52864-4 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Оглавление:
- Part I. Nanoparticles and other Advanced Technologies
- Knowledge-based design of multi-functional polymer-based nanoparticles
- Stimuli-responsive non-viral nanoparticles for gene delivery
- Sustainability in drug and nano-particle processing
- Advanced formulation approaches for proteins
- Microneedles and polymer films – delivery of peptides, proteins and nucleic acids
- Advances in vaccine delivery enhancers – small molecules and nanomaterials
- Biodegradable long acting injectables: Platform technology and industrial challenges
- Part II. Visualization Technologies
- Visualization of Nano-carriers and Drugs in Cells and Tissue
- Characterization of drug delivery systems by transmission electron microscopy
- Part III. Target Specific Delivery
- Blood-brain barrier-crossing strategies for improved treatment of CNS disorders
- Interactions of nano-systems with immune cells and cancer cells – a roadmap to clinical use?- Progress in ocular drug delivery: challenges and constraints
- New therapeutic options in pulmonal diseases – sphingolipids and sphingolipid metabolism
- Molecular therapeutics for pulmonary diseases – the need for drug targeting
- Delivery of mitochondrial RNA
- Part IV. Concerted Actions – Thinking the Drug from the Beginning
- ATMP formulations and delivery
- Preclinical testing and approval of ATMP
- Looking to the future – drug delivery in the prophylaxis and therapy of severe and chronic diseases.